For citations:
Kopat V.V., Riabchenkova A.A., Chirak E.L., Chirak E.R., Saenko A.I., Kudryavtsev I.V., Trulioff A.S., Savin T.V., Zueva E.V., Simbirtsev A.S., Totolyan A.A., Dukhovlinov I.V. Purification technology design, biochemical and immunological characteristics of the recombinant chimeric antigen for evaluation of T cell immunity against coronavirus infection. Medical Immunology (Russia). 2024;26(3):591-606. (In Russ.) https://doi.org/10.15789/1563-0625-PTD-2942
Email this article 